Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRAF | P15056 | 8/20 | 0.35 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7002126 | 0.93 | BRAF (0.36) | BRAFMALT1CA1CA2CA7 | |
| SCHEMBL6996610 | 0.90 | BRAF (0.38) | BRAFMALT1CA1CA2CA7 | |
| SCHEMBL6993854 | 0.87 | BRAF (0.33) | BRAFPDE3BPDE3A | |
| SCHEMBL7001577 | 0.87 | PTGS2 (0.34) | BRAFMALT1PDE3BPDE3A | |
| SCHEMBL7001563 | 0.85 | PTGS2 (0.34) | PDE3BPDE3A | |
| SCHEMBL7000370 | 0.84 | PTGS2 (0.42) | BRAFPDE3BPDE3A | |
| SCHEMBL7001164 | 0.84 | PTGS2 (0.38) | PDE3BPDE3A | |
| SCHEMBL6999726 | 0.82 | HSD11B1 (0.32) | PDE3BPDE3A | |
| SCHEMBL6998169 | 0.82 | PGR (0.34) | BRAF | |
| SCHEMBL6991985 | 0.81 | PTGS2 (0.42) | BRAFMALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | claimed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | claimed |
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | disclosed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | disclosed |